Available Capacity. From and after the Launch Go Date during the Term, Nisso shall at all times maintain an annual manufacturing capacity for Drug Substance of not less than [ *** ] tons in potency base at the Nihongi Facility.
Appears in 2 contracts
Sources: Supply Agreement (Replidyne Inc), Supply Agreement (Replidyne Inc)